Work

First-in-Human Clinical Trial of the IL-15 Super-Agonist Complex ALT-803 for Patients Relapsed after Allogeneic Hematopoietic Cell Transplantation

Year: 2017

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.274.274

Authors: Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott, Peter Westervelt, Michael R. Verneris, John E. Wagner, Daniel J. Weisdorf, Bruce R. Blazar, John F. DiPersio, Amanda F. Cashen, Emily K. Jeng, Amy D. Rock, Hing C. Wong, Todd A. Fehniger, Jeffrey S. Miller

Institutions: Washington University in St. Louis, University of Minnesota, Children's Hospital Colorado, University of Minnesota Medical Center, Altor BioScience (United States)

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2981433435

FWCI:

Cites:

Cited by:

Related to: 10